Home » Topics » Regulatory

Regulatory
RSS

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Nov. 6, 2009

Canadian marketing approval for BioMimetic Therapeutics' Augment Bone Graft

Nov. 5, 2009

FDA grants accelerated approval to GSK and Genmab's Arzerra antibody in CLL

Oct. 28, 2009

FDA approves Votrient for advanced renal cell cancer

Oct. 21, 2009

FDA approves Boehringer Ingelheim's Twynsta for hypertension treatment

Oct. 21, 2009

Dainippon Sumitomo's Miripla granted Japanese manufacturing and marketing approval

Oct. 20, 2009

TiGenix obtains European approval for ChondroCelect for knee cartilage regeneration

Oct. 8, 2009

FDA approves new indication of Bayer's Mirena for heavy menstrual bleeding

Oct. 6, 2009

GlaxoSmithKline's Pandemrix H1N1 vaccine approved in Europe

Oct. 1, 2009

FDA grants accelerated approval to Allos Therapeutics' Folotyn for relapsed or refractory PTCL

Sep. 28, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...